DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Zangari M, Esseltine D, Lee CK. et al.
Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma.
Br J Haematol 2005; 131 (1): 71-73
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.